How Will the Food and Drug Administration Regulate Generative AI–Enabled Medical Devices?

The US Food and Drug Administration is developing its first guidelines for regulating generative AI-enabled medical devices and has sought public comment. UpDoc's diabetes management app, a platform with a conversational AI component cleared by the FDA, offers early insight but its clearance was based on equivalence to a prior insulin calculator rather than AI-specific architecture, highlighting regulatory uncertainties.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure, and 6 sources have reported it between 19 Oct 2026 and 3 Nov 2026.